InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022
Report articles
Will release monetary final results for the fourth quarter of 2021 prior to marketplace open on Monday, April 4, 2022
Webcast scheduled for same day at 8:30am ET
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2022 (World NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) right now introduced that the Company will release economical final results for its fourth quarter fiscal 2021 ended December 31, 2021 just before economic markets open on April 4, 2022.
Posting content
InterCure executives will host a dwell convention call and audio webcast to focus on these effects at 8:30 am Jap Time, details of which are supplied under.
To access the meeting simply call, United States members be sure to dial (844) 310-5056, or for global callers, 1-706-679-4749. Meeting ID: 5661207.
Contributors can access the reside webcast by the pursuing url:
https://little bit.ly/37N92wN
A stay webcast of the conference simply call can be accessed on the ‘Events and Presentations’ section of the InterCure web-site at http://www.intercure.co.
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the primary, profitable, and swiftest developing hashish business outside the house of North The usa. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s most significant certified cannabis producer and one particular of the very first to present Excellent Producing Methods (GMP) licensed and pharmaceutical-quality clinical cannabis products and solutions. InterCure leverages its industry major distribution community, very best in class intercontinental partnerships and a high-margin vertically integrated “seed-to-sale” design to direct the speediest growing cannabis world current market outside the house of North The usa.
For extra info, pay a visit to: http://www.intercure.co.
Contact:
InterCure Ltd.
Amos Cohen, Chief Financial Officer
[email protected]